MDGL
Madrigal Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.93B
P/E Ratio
—
EPS
$-13.51
Beta
-1.04
52W High
$615.00
52W Low
$265.00
50-Day MA
$507.33
200-Day MA
$484.51
Dividend Yield
—
Profit Margin
-27.30%
Forward P/E
666.67
PEG Ratio
0.00
About Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania.
Fundamentals
| Revenue (TTM) | $1.13B |
| Gross Profit (TTM) | $1.05B |
| EBITDA | $-312.00M |
| Operating Margin | -29.80% |
| Return on Equity | -49.30% |
| Return on Assets | -17.60% |
| Revenue/Share (TTM) | $49.95 |
| Book Value | $23.59 |
| Price-to-Book | 21.96 |
| Price-to-Sales (TTM) | 10.53 |
| EV/Revenue | 10.13 |
| EV/EBITDA | -8.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 126.80% |
| Shares Outstanding | $23.06M |
| Float | $12.90M |
| % Insiders | 5.70% |
| % Institutions | 106.17% |
Historical Volatility
HV 10-Day
35.88%
HV 20-Day
42.32%
HV 30-Day
35.82%
HV 60-Day
41.08%
HV Rank
6.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($674.36 target)
3
Strong Buy11
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026